期刊文献+

基于Topomer CoMFA方法的苯并呋喃类褪黑激素受体拮抗药的三维定量构效关系研究 被引量:2

Three-dimensional Quantitative Structure Activity Relationship Study of Benzofuran Melatonin Receptor Antagonists Based on Topomer CoMFA Method
下载PDF
导出
摘要 目的:建立苯丙呋喃类化合物褪黑激素受体拮抗药的三维定量构效关系(3D-QSAR)模型。方法:使用SYBYLx2.1.1软件中的Topomer CoMFA模块对29个苯并呋喃类分子进行三维定量构效关系分析。保留母核结构切割后得到了3个R基片段,分别计算所产生的立体场与静电场。结果:对于褪黑激素受体1(MT1)和褪黑激素受体2(MT2)分别建立了可靠、合理的Topomer CoMFA模型(MT1:q2=0.650,r2=0.924;MT2:q2=0.486,r2=0.920)。结论:建立的Topomer CoMFA模型阐明了苯并呋喃类化合物分子对褪黑激素受体的生物活性的影响因素。通过分析实验化合物MT1与MT2的活性值比值(MT1/MT2),发现R2基团的电负性变化可能使该类化合物对两种受体表现出不同选择性。 Objective:To establish the three-dimensional quantitative structure-activity relationship(3D-QSAR)model of phenylpropanfuran compounds melatonin receptor antagonists.Methods:The Topomer CoMFA module in the SYBYL-x2.1.1 software was used to analyze the 3D-QSAR of 29 benzofuran molecules.After cutting the core structure,three R-based fragments were obtained,and the generated three-dimensional field and electrostatic field were calculated respectively.Results:Reliable and reasonable Topomer CoMFA models were established for melatonin receptor 1(MT1)and melatonin receptor 2(MT2)(MT1:q2=0.650,r2=0.924;MT2:q2=0.486,r2=0.920).Conclusion:The established Topomer CoMFA model clarified the influencing factors of benzofuran molecules in the biological activity of melatonin receptors.By analyzing the ratio of activity values of the experimental compounds MT1 and MT2(MT1/MT2),it was found that the electronegativity change of the R2 group may make the compounds exhibit different selectivity for the two receptors.
作者 方明阳 梁佳龙 孙智勇 王菲 Fang Mingyang;Liang Jialong;Sun Zhiyong;Wang Fei(No.946 Hospital of People’s Liberation Army Ground Force,Xinjiang Yili 835000,China;School of Pharmacy,Air Force Medical University;Shaanxi Institute for Food and Drug Control)
出处 《中国药师》 CAS 2020年第10期1910-1914,共5页 China Pharmacist
基金 军队后勤科研计划项目面上项目(编号:CLJ20J027)。
关键词 褪黑激素受体 三维定量构效关系 Topomer CoMFA Melatonin receptor Three-dimensional quantitative structure activity relationship Topomer CoMFA
  • 相关文献

参考文献13

二级参考文献91

  • 1Ferguson S S. Evolving concepts in G protein-coupled re- ceptor endocytosis:the role in receptor desensitization and signaling [J]. Pharmacol Rev,2001,53( 1 ) :1-24. 被引量:1
  • 2Sehumacher J, Jamra R A, Becker T, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression [ J]. Biol Psychiatry,2005,58 (4) :307-314. 被引量:1
  • 3Imbesi M, Uz T, Manev H. Melatonin receptor agonist rameheon activates the extracellular signal-regulated kinase I/2 in mouse cerebellar granule cells [J]. Neuro- science, 2008,155 (4) : 1160-1164. 被引量:1
  • 4Lemoine P,Nir T,Laudon M, et al. Prolonged-release me- latonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects [ J ]. J Sleep Res, 2007, 16 ( 4 ) : 372-380. 被引量:1
  • 5Wade A G, Ford I, Craw'ford G, et al. Efficacy of pro- longed release melatonin in insomnia patients aged 55-80 years:quality of sleep and next-day alertness outcomes [ J ]. Curr Med Res Opin,2007,23 (10) :2597-2605. 被引量:1
  • 6Zammit G, Erman M, Wang-Weigand S, et al. Evaluation of the efficacy and safety of rameheon in subjects with chronic insomnia [ J ]. J Clin Sleep Med, 2007,3 ( 5 ) : 495-504. 被引量:1
  • 7Mayer G,Wang-Weigand S, Roth-Schechter B, et al. Ef- ficacy and safety of 6-month nightly rameheon administra- tion in adults with ehronie primary insomnia [ J ]. Sleep, 2009,32(3) :351-360. 被引量:1
  • 8Montgomery S A,Kasper S. Severe depression and antide- pressants : focus on a pooled analysis of placebo-controlled studies on agomelatine [ J ]. Int Clin Psychopharmacol , 2007,22 (5) :283-291. 被引量:1
  • 9Quera-Salva M A, Lemoine P, Guilleminauh C. Impact of the novel antidepressant agomelatine on disturbed sleep- wake cycles in depressed patients [ J ]. Hum Psychophar- macol, 201 O, 25 ( 3 ) : 222-229. 被引量:1
  • 10Rajput V,Bromley S M. Chronic insomnia:a practical re- view [J]. Am Fam Physician,1999,60(5) :1431-1438. 被引量:1

共引文献95

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部